Viewing Study NCT04172818


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-03-06 @ 12:52 AM
Study NCT ID: NCT04172818
Status: COMPLETED
Last Update Posted: 2023-03-22
First Post: 2019-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families
Sponsor: Centre Hospitalier Universitaire, Amiens
Organization:

Study Overview

Official Title: Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families
Status: COMPLETED
Status Verified Date: 2023-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: JACintHE
Brief Summary: Allogenic hematopoietic stem cell transplantation is a specific time during hematological disease management for the patients, theirs relatives and the healthcare team. This heavy treatment is most of the time the last possible curative therapy and could cause many side effects such as infectious diseases and graft versus host reaction. The protective isolation is also a source of physical and psychological isolation. Published studies reported depressive syndrome, anxiety symptoms and post-traumatic stress disorders for patients and their families. Since 10 years ago, diaries are used in intensive care unit to limit these symptoms after a coma. In analogy, the diary for the patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long terms consequences. The investigators want to evaluate the psychological impact of a diary on the patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: